Nearly 370,000 bottles of popular antidepressant Duloxetine are recalled due to high levels of cancer-causing compounds. The US FDA issued a Class II recall for specific batches of 30 mg and 60 mg capsules. While the contaminant is suspected of causing cancer, experts note exposure risks are linked to long-term, high-level intake. Patients should consult their doctor before discontinuing medication.